POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)
1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Seq.
Identity (%)		 View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		1jjx BRAIN-TYPE FATTY
ACID BINDING PROTEIN
(Homo
sapiens)		6 / 12PHE A  16
VAL A  25
SER A  55
ALA A  75
ARG A  78
TYR A 128
None
1.24A55.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		1jjx BRAIN-TYPE FATTY
ACID BINDING PROTEIN
(Homo
sapiens)		6 / 12PHE A  16
VAL A  25
THR A  60
ALA A  75
ARG A  78
TYR A 128
None
1.18A55.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		1t0p INTEGRIN ALPHA-L
INTERCELLULAR
ADHESION MOLECULE-3
(Homo
sapiens)		5 / 12ALA B  35
SER A 270
THR A 273
ALA A 242
ASP A 244
None
1.40A16.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		1tow FATTY ACID-BINDING
PROTEIN, ADIPOCYTE
(Homo
sapiens)		7 / 12PHE A  16
VAL A  23
SER A  53
THR A  60
ALA A  75
ARG A 126
TYR A 128
CRZ  A 501 (-4.5A)
None
CRZ  A 501 ( 3.8A)
None
CRZ  A 501 ( 3.8A)
CRZ  A 501 (-3.8A)
CRZ  A 501 (-4.8A)
1.32A91.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		1tow FATTY ACID-BINDING
PROTEIN, ADIPOCYTE
(Homo
sapiens)		12 / 12PHE A  16
VAL A  25
ALA A  33
SER A  53
SER A  55
THR A  60
ALA A  75
ASP A  76
ARG A  78
CYH A 117
ARG A 126
TYR A 128
CRZ  A 501 (-4.5A)
None
CRZ  A 501 ( 4.1A)
CRZ  A 501 ( 3.8A)
CRZ  A 501 ( 4.8A)
None
CRZ  A 501 ( 3.8A)
CRZ  A 501 (-4.0A)
CRZ  A 501 (-4.7A)
CRZ  A 501 ( 3.8A)
CRZ  A 501 (-3.8A)
CRZ  A 501 (-4.8A)
0.45A91.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		2fv5 ADAM 17
(Homo
sapiens)		5 / 12VAL A 258
THR A 387
ALA A 399
ASP A 400
ARG A 257
None
1.32A20.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		2o36 THIMET
OLIGOPEPTIDASE
(Homo
sapiens)		5 / 12PHE A  84
VAL A 394
ALA A 447
ASP A 414
ARG A 418
None
1.39A10.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		3nr3 PMP2 PROTEIN
(Homo
sapiens)		10 / 12PHE A  17
VAL A  26
SER A  56
THR A  61
ALA A  76
ASP A  77
ARG A  79
CYH A 118
ARG A 127
TYR A 129
None
None
PLM  A 901 (-3.7A)
None
PLM  A 901 ( 4.0A)
PLM  A 901 (-4.0A)
None
PLM  A 901 ( 3.8A)
PLM  A 901 (-4.6A)
PLM  A 901 (-4.6A)
0.56A59.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		3nr3 PMP2 PROTEIN
(Homo
sapiens)		8 / 12PHE A  17
VAL A  26
SER A  56
THR A  61
ALA A  76
ASP A  77
CYH A 125
TYR A 129
None
None
PLM  A 901 (-3.7A)
None
PLM  A 901 ( 4.0A)
PLM  A 901 (-4.0A)
None
PLM  A 901 (-4.6A)
1.32A59.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		3wbg FATTY ACID-BINDING
PROTEIN, HEART
(Homo
sapiens)		10 / 12PHE A  16
VAL A  25
ALA A  33
SER A  55
THR A  60
ALA A  75
ASP A  76
ARG A  78
ARG A 126
TYR A 128
2AN  A 201 ( 4.9A)
None
2AN  A 201 (-3.8A)
2AN  A 201 (-3.2A)
None
2AN  A 201 ( 3.8A)
2AN  A 201 (-3.9A)
2AN  A 201 ( 4.8A)
2AN  A 201 ( 4.9A)
None
0.66A58.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		3wbg FATTY ACID-BINDING
PROTEIN, HEART
(Homo
sapiens)		7 / 12VAL A  25
ALA A  33
SER A  55
ALA A  75
ASP A  76
CYH A 124
TYR A 128
None
2AN  A 201 (-3.8A)
2AN  A 201 (-3.2A)
2AN  A 201 ( 3.8A)
2AN  A 201 (-3.9A)
None
None
1.28A58.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		3wbg FATTY ACID-BINDING
PROTEIN, HEART
(Homo
sapiens)		5 / 12VAL A  25
ALA A  33
THR A  53
ASP A  76
ARG A  78
None
2AN  A 201 (-3.8A)
2AN  A 201 ( 4.0A)
2AN  A 201 (-3.9A)
2AN  A 201 ( 4.8A)
1.09A58.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		3wbg FATTY ACID-BINDING
PROTEIN, HEART
(Homo
sapiens)		5 / 12VAL A  25
ALA A  33
THR A  53
ASP A  76
CYH A 124
None
2AN  A 201 (-3.8A)
2AN  A 201 ( 4.0A)
2AN  A 201 (-3.9A)
None
1.04A58.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		4a60 FATTY ACID-BINDING
PROTEIN 9 TESTIS
LIPID-BINDING
PROTEIN, TLBP,
TESTIS-TYPE FATTY
ACID-BINDING
PROTEIN, T-FABP
(Homo
sapiens)		10 / 12PHE A  17
VAL A  26
ALA A  34
SER A  56
THR A  61
ASP A  77
ARG A  79
CYH A 118
ARG A 127
TYR A 129
None
None
NA  A1132 ( 4.0A)
NA  A1132 (-2.9A)
None
EDO  A1134 (-3.7A)
EDO  A1134 ( 4.9A)
None
None
None
0.79A55.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		4a60 FATTY ACID-BINDING
PROTEIN 9 TESTIS
LIPID-BINDING
PROTEIN, TLBP,
TESTIS-TYPE FATTY
ACID-BINDING
PROTEIN, T-FABP
(Homo
sapiens)		10 / 12PHE A  17
VAL A  26
SER A  56
THR A  61
ALA A  76
ASP A  77
ARG A  79
CYH A 118
ARG A 127
TYR A 129
None
None
NA  A1132 (-2.9A)
None
EDO  A1134 ( 3.9A)
EDO  A1134 (-3.7A)
EDO  A1134 ( 4.9A)
None
None
None
0.73A55.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		4a60 FATTY ACID-BINDING
PROTEIN 9 TESTIS
LIPID-BINDING
PROTEIN, TLBP,
TESTIS-TYPE FATTY
ACID-BINDING
PROTEIN, T-FABP
(Homo
sapiens)		5 / 12VAL A  26
ALA A  34
THR A  54
ASP A  77
ARG A  79
None
NA  A1132 ( 4.0A)
None
EDO  A1134 (-3.7A)
EDO  A1134 ( 4.9A)
1.11A55.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		4mzv EPITHELIAL CELL
ADHESION MOLECULE
(Homo
sapiens)		5 / 12ALA A  64
ALA A 210
ASP A 208
ARG A 140
TYR A  95
None
1.41A23.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		4nef AQUAPORIN-2
(Homo
sapiens)		5 / 12VAL A  90
ALA A 186
SER A 182
THR A 138
ALA A  70
None
1.22A22.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		4nns FATTY ACID-BINDING
PROTEIN, ADIPOCYTE
(Homo
sapiens)		6 / 12PHE A  16
VAL A  23
SER A  53
THR A  60
ARG A 126
TYR A 128
None
None
75D  A 201 (-2.5A)
None
75D  A 201 (-3.9A)
None
1.24A81.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		4nns FATTY ACID-BINDING
PROTEIN, ADIPOCYTE
(Homo
sapiens)		12 / 12PHE A  16
VAL A  25
ALA A  33
SER A  53
SER A  55
THR A  60
ALA A  75
ASP A  76
ARG A  78
CYH A 117
ARG A 126
TYR A 128
None
None
75D  A 201 ( 4.1A)
75D  A 201 (-2.5A)
75D  A 201 ( 4.7A)
None
75D  A 201 (-3.6A)
75D  A 201 (-4.1A)
75D  A 201 (-4.7A)
75D  A 201 (-3.5A)
75D  A 201 (-3.9A)
None
0.43A81.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		5b29 FATTY ACID-BINDING
PROTEIN, HEART
(Homo
sapiens)		9 / 12VAL A  25
ALA A  33
SER A  55
THR A  60
ALA A  75
ASP A  76
ARG A  78
ARG A 126
TYR A 128
None
PLM  A 200 ( 3.7A)
PLM  A 200 ( 4.1A)
PLM  A 200 ( 4.8A)
PLM  A 200 ( 4.0A)
PLM  A 200 ( 4.3A)
None
PLM  A 200 (-3.7A)
PLM  A 200 (-4.8A)
0.68A62.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		5b29 FATTY ACID-BINDING
PROTEIN, HEART
(Homo
sapiens)		6 / 12VAL A  25
SER A  55
ALA A  75
ASP A  76
CYH A 124
TYR A 128
None
PLM  A 200 ( 4.1A)
PLM  A 200 ( 4.0A)
PLM  A 200 ( 4.3A)
None
PLM  A 200 (-4.8A)
1.26A62.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		5c5x AQUAPORIN-5
(Homo
sapiens)		5 / 12VAL A  91
ALA A 187
SER A 183
THR A 139
ALA A  71
None
1.30A21.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		5hz5 FATTY ACID-BINDING
PROTEIN, EPIDERMAL
(Homo
sapiens)		9 / 12PHE A  19
VAL A  28
SER A  58
THR A  63
ALA A  78
ASP A  79
ARG A  81
ARG A 129
TYR A 131
65X  A 203 ( 4.7A)
None
65X  A 203 ( 3.7A)
65X  A 203 ( 4.8A)
65X  A 203 (-3.5A)
65X  A 203 ( 4.2A)
None
65X  A 203 (-3.9A)
None
0.60A47.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		5n2s SOLUBLE CYTOCHROME
B562,ADENOSINE
RECEPTOR A1
(Escherichia
coli;
Homo
sapiens)		5 / 12PHE A1348
ALA A1196
SER A1240
ALA A1159
ASP A1160
None
8K8  A2001 ( 3.5A)
None
None
None
1.46A16.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		5tf2 PROLACTIN REGULATORY
ELEMENT-BINDING
PROTEIN
(Homo
sapiens)		5 / 12SER A 304
THR A 347
ALA A 373
ASP A 375
ARG A 377
None
1.47A15.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		5wbg CYTOCHROME P450 2B6
(Homo
sapiens)		5 / 12PHE A 377
VAL A 388
ALA A  87
THR A 394
ARG A 378
None
1.46A20.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		5zal ENDORIBONUCLEASE
DICER
(Homo
sapiens)		5 / 12VAL A1740
THR A1328
ALA A1710
ASP A1713
ARG A1736
None
1.06A20.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_A_TDZA201_2
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		1tow FATTY ACID-BINDING
PROTEIN, ADIPOCYTE
(Homo
sapiens)		4 / 4TYR A  19
MET A  20
PRO A  38
ILE A 104
None
CRZ  A 501 ( 3.8A)
CRZ  A 501 (-4.5A)
CRZ  A 501 ( 4.8A)
0.27A91.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_A_TDZA201_2
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		3nr3 PMP2 PROTEIN
(Homo
sapiens)		4 / 4TYR A  20
MET A  21
PRO A  39
ILE A 105
None
PLM  A 901 (-3.7A)
SO4  A 903 ( 4.8A)
PLM  A 901 ( 4.5A)
0.54A59.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_A_TDZA201_2
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		4a60 FATTY ACID-BINDING
PROTEIN 9 TESTIS
LIPID-BINDING
PROTEIN, TLBP,
TESTIS-TYPE FATTY
ACID-BINDING
PROTEIN, T-FABP
(Homo
sapiens)		4 / 4TYR A  20
MET A  21
PRO A  39
ILE A 105
None
EDO  A1134 (-4.5A)
None
None
0.48A55.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_A_TDZA201_2
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		4nns FATTY ACID-BINDING
PROTEIN, ADIPOCYTE
(Homo
sapiens)		4 / 4TYR A  19
MET A  20
PRO A  38
ILE A 104
None
75D  A 201 (-3.6A)
75D  A 201 (-4.4A)
75D  A 201 ( 4.4A)
0.30A81.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_A_TDZA201_2
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		5hz5 FATTY ACID-BINDING
PROTEIN, EPIDERMAL
(Homo
sapiens)		4 / 4TYR A  22
MET A  23
PRO A  41
ILE A 107
65X  A 203 ( 4.7A)
65X  A 203 ( 3.9A)
65X  A 203 (-4.4A)
65X  A 203 (-3.9A)
0.32A47.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QM9_B_TDZB202_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		1hlg LIPASE, GASTRIC
(Homo
sapiens)		5 / 12PHE A  62
TYR A 149
THR A  34
ALA A 133
ILE A 158
None
1.31A16.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_B_TDZB202_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		1jjx BRAIN-TYPE FATTY
ACID BINDING PROTEIN
(Homo
sapiens)		6 / 12PHE A  16
TYR A  19
VAL A  25
SER A  55
ARG A  78
TYR A 128
None
1.03A55.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_B_TDZB202_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		1jjx BRAIN-TYPE FATTY
ACID BINDING PROTEIN
(Homo
sapiens)		7 / 12PHE A  16
TYR A  19
VAL A  25
THR A  60
ALA A  75
ARG A  78
TYR A 128
None
1.06A55.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_B_TDZB202_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		1tow FATTY ACID-BINDING
PROTEIN, ADIPOCYTE
(Homo
sapiens)		12 / 12PHE A  16
TYR A  19
VAL A  25
SER A  53
SER A  55
THR A  60
ALA A  75
ARG A  78
ILE A 104
CYH A 117
ARG A 126
TYR A 128
CRZ  A 501 (-4.5A)
None
None
CRZ  A 501 ( 3.8A)
CRZ  A 501 ( 4.8A)
None
CRZ  A 501 ( 3.8A)
CRZ  A 501 (-4.7A)
CRZ  A 501 ( 4.8A)
CRZ  A 501 ( 3.8A)
CRZ  A 501 (-3.8A)
CRZ  A 501 (-4.8A)
0.48A91.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_B_TDZB202_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		1tow FATTY ACID-BINDING
PROTEIN, ADIPOCYTE
(Homo
sapiens)		7 / 12PHE A  16
VAL A  23
SER A  53
THR A  60
ALA A  75
ARG A 126
TYR A 128
CRZ  A 501 (-4.5A)
None
CRZ  A 501 ( 3.8A)
None
CRZ  A 501 ( 3.8A)
CRZ  A 501 (-3.8A)
CRZ  A 501 (-4.8A)
1.27A91.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QM9_B_TDZB202_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		3h1v GLUCOKINASE
(Homo
sapiens)		5 / 12PHE X 423
VAL X 408
THR X 255
ALA X 232
ILE X 390
None
1.21A18.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QM9_B_TDZB202_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		3hf8 TRYPTOPHAN
5-HYDROXYLASE 1
(Homo
sapiens)		5 / 12VAL A 316
THR A 225
ALA A 287
ILE A 229
CYH A 252
None
1.45A19.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_B_TDZB202_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		3nr3 PMP2 PROTEIN
(Homo
sapiens)		11 / 12PHE A  17
TYR A  20
VAL A  26
SER A  56
THR A  61
ALA A  76
ARG A  79
ILE A 105
CYH A 118
ARG A 127
TYR A 129
None
None
None
PLM  A 901 (-3.7A)
None
PLM  A 901 ( 4.0A)
None
PLM  A 901 ( 4.5A)
PLM  A 901 ( 3.8A)
PLM  A 901 (-4.6A)
PLM  A 901 (-4.6A)
0.63A59.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_B_TDZB202_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		3nr3 PMP2 PROTEIN
(Homo
sapiens)		7 / 12PHE A  17
VAL A  26
SER A  56
ALA A  76
CYH A 125
ARG A 127
TYR A 129
None
None
PLM  A 901 (-3.7A)
PLM  A 901 ( 4.0A)
None
PLM  A 901 (-4.6A)
PLM  A 901 (-4.6A)
1.49A59.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_B_TDZB202_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		3nr3 PMP2 PROTEIN
(Homo
sapiens)		5 / 12TYR A  20
VAL A  26
THR A  54
ARG A  79
ILE A 105
None
None
PLM  A 901 ( 4.6A)
None
PLM  A 901 ( 4.5A)
1.22A59.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_B_TDZB202_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		3wbg FATTY ACID-BINDING
PROTEIN, HEART
(Homo
sapiens)		9 / 12PHE A  16
TYR A  19
VAL A  25
SER A  55
THR A  60
ALA A  75
ARG A  78
ARG A 126
TYR A 128
2AN  A 201 ( 4.9A)
2AN  A 201 (-4.8A)
None
2AN  A 201 (-3.2A)
None
2AN  A 201 ( 3.8A)
2AN  A 201 ( 4.8A)
2AN  A 201 ( 4.9A)
None
0.62A58.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_B_TDZB202_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		3wbg FATTY ACID-BINDING
PROTEIN, HEART
(Homo
sapiens)		5 / 12VAL A  25
SER A  55
ALA A  75
CYH A 124
TYR A 128
None
2AN  A 201 (-3.2A)
2AN  A 201 ( 3.8A)
None
None
1.21A58.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_B_TDZB202_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		4a60 FATTY ACID-BINDING
PROTEIN 9 TESTIS
LIPID-BINDING
PROTEIN, TLBP,
TESTIS-TYPE FATTY
ACID-BINDING
PROTEIN, T-FABP
(Homo
sapiens)		11 / 12PHE A  17
TYR A  20
VAL A  26
SER A  56
THR A  61
ALA A  76
ARG A  79
ILE A 105
CYH A 118
ARG A 127
TYR A 129
None
None
None
NA  A1132 (-2.9A)
None
EDO  A1134 ( 3.9A)
EDO  A1134 ( 4.9A)
None
None
None
None
0.74A55.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_B_TDZB202_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		4a60 FATTY ACID-BINDING
PROTEIN 9 TESTIS
LIPID-BINDING
PROTEIN, TLBP,
TESTIS-TYPE FATTY
ACID-BINDING
PROTEIN, T-FABP
(Homo
sapiens)		5 / 12TYR A  20
VAL A  26
THR A  54
ARG A  79
ILE A 105
None
None
None
EDO  A1134 ( 4.9A)
None
1.22A55.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_B_TDZB202_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		4nns FATTY ACID-BINDING
PROTEIN, ADIPOCYTE
(Homo
sapiens)		12 / 12PHE A  16
TYR A  19
VAL A  25
SER A  53
SER A  55
THR A  60
ALA A  75
ARG A  78
ILE A 104
CYH A 117
ARG A 126
TYR A 128
None
None
None
75D  A 201 (-2.5A)
75D  A 201 ( 4.7A)
None
75D  A 201 (-3.6A)
75D  A 201 (-4.7A)
75D  A 201 ( 4.4A)
75D  A 201 (-3.5A)
75D  A 201 (-3.9A)
None
0.38A81.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_B_TDZB202_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		4nns FATTY ACID-BINDING
PROTEIN, ADIPOCYTE
(Homo
sapiens)		6 / 12PHE A  16
VAL A  23
SER A  53
THR A  60
ARG A 126
TYR A 128
None
None
75D  A 201 (-2.5A)
None
75D  A 201 (-3.9A)
None
1.22A81.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_B_TDZB202_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		5b29 FATTY ACID-BINDING
PROTEIN, HEART
(Homo
sapiens)		8 / 12TYR A  19
VAL A  25
SER A  55
THR A  60
ALA A  75
ARG A  78
ARG A 126
TYR A 128
None
None
PLM  A 200 ( 4.1A)
PLM  A 200 ( 4.8A)
PLM  A 200 ( 4.0A)
None
PLM  A 200 (-3.7A)
PLM  A 200 (-4.8A)
0.51A62.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_B_TDZB202_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		5b29 FATTY ACID-BINDING
PROTEIN, HEART
(Homo
sapiens)		5 / 12VAL A  25
SER A  55
ALA A  75
CYH A 124
TYR A 128
None
PLM  A 200 ( 4.1A)
PLM  A 200 ( 4.0A)
None
PLM  A 200 (-4.8A)
1.23A62.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_B_TDZB202_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		5hz5 FATTY ACID-BINDING
PROTEIN, EPIDERMAL
(Homo
sapiens)		10 / 12PHE A  19
TYR A  22
VAL A  28
SER A  58
THR A  63
ALA A  78
ARG A  81
ILE A 107
ARG A 129
TYR A 131
65X  A 203 ( 4.7A)
65X  A 203 ( 4.7A)
None
65X  A 203 ( 3.7A)
65X  A 203 ( 4.8A)
65X  A 203 (-3.5A)
None
65X  A 203 (-3.9A)
65X  A 203 (-3.9A)
None
0.59A47.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_B_TDZB202_2
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		1tow FATTY ACID-BINDING
PROTEIN, ADIPOCYTE
(Homo
sapiens)		4 / 4MET A  20
PRO A  38
ASP A  76
ARG A 106
CRZ  A 501 ( 3.8A)
CRZ  A 501 (-4.5A)
CRZ  A 501 (-4.0A)
None
0.32A91.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_B_TDZB202_2
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		3nr3 PMP2 PROTEIN
(Homo
sapiens)		4 / 4MET A  21
PRO A  39
ASP A  77
ARG A 107
PLM  A 901 (-3.7A)
SO4  A 903 ( 4.8A)
PLM  A 901 (-4.0A)
PLM  A 901 (-3.7A)
0.41A59.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_B_TDZB202_2
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		3wbg FATTY ACID-BINDING
PROTEIN, HEART
(Homo
sapiens)		4 / 4MET A  20
PRO A  38
ASP A  76
ARG A 106
2AN  A 201 ( 3.9A)
2AN  A 201 ( 4.3A)
2AN  A 201 (-3.9A)
None
0.51A58.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_B_TDZB202_2
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		4a60 FATTY ACID-BINDING
PROTEIN 9 TESTIS
LIPID-BINDING
PROTEIN, TLBP,
TESTIS-TYPE FATTY
ACID-BINDING
PROTEIN, T-FABP
(Homo
sapiens)		4 / 4MET A  21
PRO A  39
ASP A  77
ARG A 107
EDO  A1134 (-4.5A)
None
EDO  A1134 (-3.7A)
None
0.88A55.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_B_TDZB202_2
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		4nns FATTY ACID-BINDING
PROTEIN, ADIPOCYTE
(Homo
sapiens)		4 / 4MET A  20
PRO A  38
ASP A  76
ARG A 106
75D  A 201 (-3.6A)
75D  A 201 (-4.4A)
75D  A 201 (-4.1A)
75D  A 201 ( 4.6A)
0.26A81.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_B_TDZB202_2
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		5b29 FATTY ACID-BINDING
PROTEIN, HEART
(Homo
sapiens)		4 / 4MET A  20
PRO A  38
ASP A  76
ARG A 106
PLM  A 200 ( 4.0A)
PLM  A 200 ( 4.9A)
PLM  A 200 ( 4.3A)
None
0.54A62.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QM9_B_TDZB202_2
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		5hz5 FATTY ACID-BINDING
PROTEIN, EPIDERMAL
(Homo
sapiens)		4 / 4MET A  23
PRO A  41
ASP A  79
ARG A 109
65X  A 203 ( 3.9A)
65X  A 203 (-4.4A)
65X  A 203 ( 4.2A)
65X  A 203 (-4.0A)
0.33A47.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QM9_B_TDZB202_2
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)		5xjv DUAL SPECIFICITY
PROTEIN PHOSPHATASE
13 ISOFORM A
(Homo
sapiens)		4 / 4MET A 145
PRO A 167
ASP A 179
ARG A 160
None
1.13A18.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VN0_A_TDZA501_1
(CYTOCHROME P450 2C8)		1a4i METHYLENETETRAHYDROF
OLATE DEHYDROGENASE
/
METHENYLTETRAHYDROFO
LATE CYCLOHYDROLASE
(Homo
sapiens)		5 / 12ILE A  70
LEU A  88
ASN A  89
VAL A  81
ILE A 118
None
1.18A19.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VN0_A_TDZA501_1
(CYTOCHROME P450 2C8)		1qc5 PROTEIN (ALPHA1
BETA1 INTEGRIN)
(Homo
sapiens)		5 / 12ILE B 416
THR B 412
VAL B 455
GLU B 495
THR B 497
None
1.14A17.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VN0_A_TDZA501_1
(CYTOCHROME P450 2C8)		1vcb PROTEIN (ELONGIN C)
(Homo
sapiens)		5 / 12ILE B  42
THR B  41
PHE B  29
LEU B  21
VAL B  73
None
1.19A12.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VN0_A_TDZA501_1
(CYTOCHROME P450 2C8)		2e9w MAST/STEM CELL
GROWTH FACTOR
RECEPTOR
(Homo
sapiens)		5 / 12THR A 391
PHE A 316
ASN A 314
VAL A 335
ILE A 313
None
1.23A22.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VN0_A_TDZA501_1
(CYTOCHROME P450 2C8)		2hwx TELOMERASE-BINDING
PROTEIN EST1A
(Homo
sapiens)		5 / 12ILE A1256
LEU A1283
ASN A1281
VAL A1303
ILE A1278
None
1.16A17.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2VN0_A_TDZA501_1
(CYTOCHROME P450 2C8)		2nnj CYTOCHROME P450 2C8
(Homo
sapiens)		11 / 12ILE A 106
THR A 107
ASN A 204
PHE A 205
LEU A 208
ASN A 209
VAL A 237
VAL A 296
GLU A 300
THR A 301
ILE A 476
PLM  A 502 (-4.6A)
None
None
None
225  A 501 ( 4.3A)
None
None
None
None
HEM  A 500 ( 3.7A)
225  A 501 ( 3.9A)
0.60A100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VN0_A_TDZA501_1
(CYTOCHROME P450 2C8)		3g65 CHECKPOINT PROTEIN
HUS1
(Homo
sapiens)		5 / 12LEU C 192
VAL C 201
GLU C 195
THR C 196
ILE C 234
None
1.03A21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VN0_A_TDZA501_1
(CYTOCHROME P450 2C8)		4kbo STRESS-70 PROTEIN,
MITOCHONDRIAL
(Homo
sapiens)		5 / 12ILE A 191
LEU A 171
VAL A 216
VAL A  56
GLU A 179
None
1.13A21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VN0_A_TDZA501_1
(CYTOCHROME P450 2C8)		4kbo STRESS-70 PROTEIN,
MITOCHONDRIAL
(Homo
sapiens)		5 / 12ILE A 191
THR A 192
LEU A 171
VAL A 216
GLU A 179
None
1.09A21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VN0_A_TDZA501_1
(CYTOCHROME P450 2C8)		5o2v NUCLEOLYSIN TIA-1
ISOFORM P40
(Homo
sapiens)		5 / 12ILE A  71
LEU A  26
VAL A  18
VAL A  11
ILE A  30
None
1.24A9.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2VN0_A_TDZA501_1
(CYTOCHROME P450 2C8)		5xxi CYTOCHROME P450 2C9
(Homo
sapiens)		5 / 12ASN A 204
LEU A 208
VAL A 237
GLU A 300
THR A 301
LSN  A 501 (-3.7A)
LSN  A 501 (-3.9A)
LSN  A 501 (-4.5A)
None
HEM  A 504 (-4.0A)
1.03A78.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VN0_A_TDZA501_1
(CYTOCHROME P450 2C8)		6c01 ECTONUCLEOTIDE
PYROPHOSPHATASE/PHOS
PHODIESTERASE FAMILY
MEMBER 3
(Homo
sapiens)		5 / 12ILE A 710
THR A 711
LEU A 593
ASN A 594
GLU A 587
None
None
None
NAG  A 925 (-1.9A)
None
1.13A13.71